28 JANUARY 2015
Sysmex Corporation (HQ: Kobe, Japan; Chairman and CEO: Hisashi Ietsugu) announced today its launch of the CS-1600 automated blood coagulation analyzer, a new compact model in the hemostasis field.
In the past, hemostasis was primarily used to check hemorrhagic tendency for diagnosing hemorrhagic disorders such as hemophilia. In recent years however, changing eating habits have led to an increase in lifestyle diseases and the prevalence of vascular diseases has risen in line with the aging of the population. Such factors have led to a greater number of thrombotic diseases, such as myocardial and cerebral infarction. Correct eating habits and the use of platelet inhibitors and anticoagulation agents can be important for the control of thrombotic diseases. This situation has led to an increasing need for high-quality testing to detect thrombotic tendency and for health monitoring.
Reflecting this environment, the global market for hemostasis has grown. In future, the rate of growth is expected to be particularly high in China and other emerging markets that are enjoying rapid economic expansion.
In 1995, Sysmex entered into a distribution agreement with Siemens Healthcare Diagnostics Inc., which has a leading share of the global market for hemostasis reagents. The two companies supply and distribute each other's instruments and reagents globally, maintaining the top global market share in the hemostasis field.
In 2006, Sysmex introduced the CS-2000i/2100i automated coagulation blood analyzer, the first in the world to employ a multi-wavelength transmitted light detection system. In 2011, we launched a high-end automated blood coagulation analyzer, the CS-5100. In 2014, we augmented functionality and ease of use in the CS-5100 and incorporated new analytical functions in a new desktop model, the CS-2400/2500, enhancing our lineup of hemostasis instruments and reagents and meeting customer demand by providing solutions including support services. In these ways, Sysmex has continued with the global introduction of the CS-Series.
The new CS-1600 is a compact model in the CS-Series, incorporating the technological capabilities and expertise Sysmex has accumulated in the hemostasis field. Carrying forward the core performance and functionality of the CS-5100, the model aimed principally at large-scale laboratories and our high-performance desktop model, the CS-2400/2500, the CS-1600 is more compact and easy to use. Representing the ongoing progress of the CS-Series, the CS-1600 targets laboratories which run a relatively small number of tests. We also anticipate rising demand for use as a backup instrument.
The new model incorporates SNCS® (Sysmex Network Communication Systems) functionality, allowing for online quality control and preventive maintenance, increasing the level of support services available in the hemostasis field.
Starting with a launch in Japan, Sysmex will progressively introduce this model in global markets, including China and other parts of Asia, as well as Russia.
Going forward, Sysmex aims to continue reducing the burden on patients and enhancing their quality of life, as well as instilling its customers with confidence. Sysmex and Siemens Healthcare Diagnostics will leverage their global networks to respond to broad-based customer needs in the hemostasis field, which are becoming increasingly diverse and sophisticated. As a result, we aim to contribute to diagnosis and health monitoring by offering highly reliable test results.
New Product Overview
Automated Blood Coagulation Analyzer CS-1600
Japan: January 28, 2015 (Outside Japan: to be launched successively in individual countries after receiving regulatory approval)
Up to 120 tests/hour
PT, APTT, Fbg, TTO, HpT, Coagulation Factors (extrinsic and intrinsic)
AT, PLG, α2PI, PC
D-Dimer, FDP, PIC, FM, VWF:Ag
* Target market: Japan
Multi-wavelength detection technology - a core technology for the CS-Series - provides highly reliable data by switching wavelengths according to an internal algorithm
Blood sample volume check ensures against test results being affected by sample volumes that are too high or too low
Measurement progress and reagent monitoring screens to allow at-a-glance monitoring; traceability function
Color touch-screen for simple usability
Handy barcode reader for automatic registration of reagents
Decrease reagent waste through reagent vial dead volume reduction
Automatic startup and backup functions for improved operating efficiency
Automated Blood Coagulation Analyzer CS-1600
15 JANUARY 2015
Sysmex Corporation (HQ: Kobe, Japan; Chairman and CEO: Hisashi Ietsugu) announced today the launch of the XN-L series automated hematology analyzer.
By augmenting the Company's lineup with the compact XN-L series, Sysmex aims to better meet the diverse needs of customers centered in emerging markets. The XN-L delivers performance similar to or the same as the XN-Series1, Sysmex's flagship model.
In recent years, rapid rates of economic growth in emerging markets have been prompting the development of healthcare infrastructures. This factor, plus an increasing awareness of health and healthcare, are spurring demand for medical care and testing. At the same time, healthcare needs in advanced countries are growing more diverse, owing to efforts to curtail costs and respond to aging populations, as well as to making inroads in preventive medicine and personalized medicine.
Since the time of its establishment, Sysmex has concentrated on its mainstay field of hematology, which involves the analysis of red blood cells, white blood cells, platelets and other blood components. Through these efforts, the Company has acquired the leading share of the global hematology market.
The XN-Series, which launched in 2011, helps to enhance clinical value by providing a low-WBC mode2 and body fluid mode3, as well as providing reticulocyte hemoglobin equivalent4.
This new addition to the XN-Series carries forth the functionality and operability that have earned the XN-Series a strong reputation throughout the world. This model features increased compactness by internalizing the pneumatic power source and miniaturizing detectors. The result provides one of the most compact instruments in its class. In addition to five-part white blood cell differentiation, the XN-L also conducts automated reticulocyte analysis using the fluorescent flow cytometry method.
As well as being compact, the XN-L series offers high levels of performance and operability, which customers have come to expect from Sysmex. The model is designed to meet a diverse range of needs. Aimed primarily for use in small and medium-sized healthcare facilities, the XN-L series is also suited for emergency laboratories at large-scale institutions that have already adopted the XN-Series.
The new series also is compatible with the Sysmex Network Communication Systems (SNCS®5), which allows online monitoring of the instrument's operating conditions. This function enables real-time external quality control and web-based information delivery, helping to pre-empt sudden malfunctions.
Additionally, this new product can help meet the demand in emerging markets for flagging blood cell shape changes that occurs in cases of malaria, one of the world's most deadly infectious diseases.
Going forward, Sysmex aims to meet increasingly sophisticated needs in emerging markets, including China and other parts of Asia, that are slated for further growth by providing high-value-added testing.
New Product Overview
Automated Hematology Analyzer XN-L series
January 2015 (To be launched successively in individual countries after receiving regulatory approval)
Up to 70 tests/hour (with option）
Reagent management functions:
Uses RFID tags to support appropriate reagent
Cartridge-type staining packages facilitate reagent cassette placement
Remaining reagent display screen allows visual monitoring
Employs the "Silent Design"® concept, which provides a simplified system of operation and interface based on careful study of laboratory processes, and the relationship between the operator and the instrument.
Automated Hematology Analyzers launched in 2011
Refer to the press release dated May 10, 2011:
"Sysmex Launches the XN-Series of Flagship Models in the Hematology Field
- Securing Our Position as the Undisputed Global Leader in Hematology -"
2 Low-WBC mode:
Using this mode allows the number of neutrophils in samples with low white blood cell counts to be reported, something that in the past was problematic for automated hematology analyzers, allowing for chemotherapy monitoring and engraftment monitoring following transplants. Using this mode helps reduce the number of working hours required for visual classification and allows for the delivery of swift and accurate test results.
3 Body fluid mode:
Analyzes samples of various types, such as cerebrospinal fluid, pleural fluid, ascites fluid and synovial fluid
4 Reticulocyte hemoglobin equivalent:
A standard for effectively determining changes in the amount of iron in the blood when diagnosing iron deficiency in cases of renal anemia and for chronic kidney disease, especially in dialysis patients.
This online support service connects the Sysmex's server and customers' products via an Internet connection to enable real-time external quality control, to monitor instrument conditions, and to get scientific information and. The content of support services varies by region. A separate agreement is required to use this service.
Sampler type, which includes a sampler that allows 20 samples to be measured consecutively
Cap-piercing type, which allows measurement while the caps of blood collection tubes remain affixed
Open type, in which blood collection tube caps are opened for measurement